Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tanabe Pharma Corporation
Age
20–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients meeting DSM-IV-TR criteria for schizophrenia
PANSS total score \<= 120 during the observation period
Patients who have been treated with oral antipsychotics within 4 weeks before informed consent
Patients whose consent is obtained from themselves in written form
You may not be if
Patients who have defined as any mental disorder other than "Schizophrenia" based on the criteria of DSM-IV-TR
History of drug or alcohol abuse
Concurrent Parkinson's disease
History of, or concurrent spastic disorders like epilepsy, cerebrovascular disease, anuresis or adynamic(= paralytic) ileus, malignant syndrome, diabetes, hepatic disorder
Patients who exhibit abnormalities on Physical Examination, have abnormal vital signs, ECG, or clinical laboratory values
Current cataract during the observation period
History of shock or anaphylactoid symptoms to drugs
The information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
